查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1933318

临床试验人工智慧市场规模、占有率、成长、全球产业分析：依类型、应用、区域洞察和预测（2026-2034 年）

AI in Clinical Trials Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 190 Pages | 商品交期: 请询问到货日

价格

临床试验人工智慧市场成长驱动因素

由于药物研发日益复杂、临床试验成本不断上升以及人工智慧技术在优化试验流程方面的应用，全球临床试验人工智慧市场正经历快速成长。该市场在 2025 年的估值为 38 亿美元，2026 年成长至 55 亿美元，预计到 2034 年将达到 1,209.1 亿美元，预测期内复合年增长率高达 47.14%。

人工智慧正日益融入临床试验设计、实施、监测和数据分析的各个阶段。这些人工智慧技术正在帮助製药公司和合约研究组织 (CRO) 加快研发进程、简化患者招募、实现资料清洗自动化并支援适应性试验设计。 例如，IQVIA Inc. 于 2022 年 9 月报告称，与传统试验流程相比，分散式临床试验在时间和成本方面均实现了显着节省。

该市场由 IQVIA Inc.、达梭系统和 AiCure 等公司引领，这些公司强大的区域影响力、广泛的产品组合和创新的 AI 解决方案为其市场领导地位提供了支撑。

市场动态

市场驱动因素

扩大采用基于 AI 的解决方案来应对临床试验的高成本和复杂性是关键驱动因素。 AI 可以加快患者招募、即时监测和预测结果建模，从而缩短试验週期并降低失败风险。全球临床试验数量的不断增加进一步加速了 AI 的应用。

市场限制因子

资料隐私和监管合规仍然是主要的限制因素。 美国的 HIPAA 和欧洲的 GDPR 等法规限制了跨国资料交换和多中心协作，增加了营运成本和时间。这些因素减缓了人工智慧在国际临床试验中的应用。

市场机会

新兴市场临床试验的扩展蕴藏着巨大的成长潜力。亚太地区、拉丁美洲以及中东和非洲等地区具有成本优势，且拥有尚未开发的患者群。人工智慧可以优化这些地区分散的医疗保健数据和试验物流，从而实现更快、更有效率的试验执行。

市场挑战

将人工智慧解决方案与传统 IT 系统整合面临诸多挑战。传统的电子资料采集 (EDC) 系统、纸本记录和分散的 IT 基础设施阻碍了人工智慧的无缝实施。即使部署了人工智慧工具，低效的整合也会限制其潜力。

市场趋势

一个关键趋势是转向分散式和混合式临床试验的转变。 这些包括远端患者监测、远距医疗和分散式研究药物分发。分散式临床试验 (DCT) 模型的采用率从疫情前的 28% 增长到疫情后的 87%，95% 的申办方计划进一步采用，这凸显了人工智慧在支援这些模型方面的强大作用。

细分分析

依产品/服务：

  • 到 2026 年，服务细分市场将占主导地位，市场占有率达 52.74%，这主要得益于外包给合约研究组织 (CRO) 和专业服务提供者。
  • 软体/平台在数据分析、患者监测和试验管理方面对服务进行了补充。

依技术：

  • 到 2026 年，机器学习 (ML) 将占 55.90% 的市场占有率，并在预测分析和试验优化方面得到广泛应用。
  • 自然语言处理 (NLP) 预计在预测期内将以 44.74% 的复合年增长率增长。

依应用领域划分：

  • 病患招募和留存将在 2026 年以 31.45% 的市场占有率引领市场，有助于优化入组流程并减少试验延误。
  • 预测分析和结果建模预计将以 52.05% 的市占率成长。

依专科领域划分：

  • 肿瘤学将在 2026 年以 39.25% 的市占率引领市场，这主要得益于人工智慧在复杂药物分子和生物标记方面的应用。
  • 神经病学预计在预测期内将以 48.98% 的复合年增长率增长。

依最终使用者划分：

  • 到 2025 年，製药公司将以 59.9% 的市场占有率引领市场，它们将利用庞大的临床数据集和合作伙伴关係来实施人工智慧。
  • 合约研究组织 (CRO) 预计将以 48.56% 的复合年增长率成长。

区域展望

  • 北美：在 2025 年以 19.8 亿美元的市场规模引领市场，预计到 2026 年将成长至 28.7 亿美元，这主要得益于美国临床试验投资的推动。预计到 2026 年，美国市场规模将达到 26.4 亿美元。
  • 欧洲：2025 年市场规模为 7.5 亿美元，由于人工智慧在肿瘤学和罕见疾病试验中的应用，预计将实现强劲增长。 预计到2026年，英国、德国和法国的市场规模将分别达到2.3亿美元、2.6亿美元和1.4亿美元。 亚太地区：预计到2025年，亚太地区市场规模将达到8.3亿美元，其中日本、中国和印度的市场规模预计到2026年将分别达到2.7亿美元、3.1亿美元和2.4亿美元。 拉丁美洲：预计2025年，拉丁美洲市场规模将达到1.5亿美元，成长较为温和。 中东和非洲：海湾合作委员会（GCC）的市场规模预计到2025年将达到4000万美元，随着其法院基础设施的现代化，该市场正稳步增长。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 人工智慧在临床试验中的技术进步
  • 主要国家的监管环境
  • 在临床试验中采用和实施人工智慧解决方案所面临的挑战
  • 人工智慧在临床试验中的关键绩效指标
  • 主要产业发展动态－併购、合作等

章节5：全球临床试验人工智慧市场分析、洞察与预测（2021-2034）

  • 市场分析、洞察与预测 - 依产品/服务分类
    • 软体/平台
    • 服务
  • 市场分析、洞察与预测 - 依技术分类
    • 机器学习
    • 自然语言处理
    • 其他
  • 市场分析、洞察与预测 - 依应用分类
    • 病患招募与保留
    • 研究设计与方案优化
    • 资料收集与管理
    • 预测分析与结果模型
    • 其他
  • 市场分析、洞察与预测 - 依专业领域
    • 肿瘤科
    • 神经科
    • 心血管科
    • 其他
  • 市场分析、洞察与预测 - 依最终用户划分
    • 製药公司
    • 合约研究组织 (CRO)
    • 其他
  • 市场分析、洞察与预测 - 依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美临床试验人工智慧市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲临床试验人工智慧临床试验市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章：亚太地区临床试验人工智慧市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章：拉丁美洲临床试验人工智慧市场分析、洞察与预测2021-2034

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章 中东和非洲临床试验人工智慧市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会
    • 南非
    • 中东和非洲其他地区

第十一章 竞争分析

  • 全球市占率分析（2025）
  • 公司简介
  • IQVIA Inc.
  • Dassault Systemes
  • AiCure
  • Insilico Medicine
  • TEMPUS
  • Median Technologies
  • Saama
  • IBM
  • NVIDIA Corporation
  • Phesi
Product Code: FBI114081

Growth Factors of AI in clinical trials Market

The global AI in clinical trials market is witnessing exponential growth due to the increasing complexity of drug development, rising clinical trial costs, and the adoption of AI technologies to optimize trial processes. The market was valued at USD 3.8 billion in 2025, expected to grow to USD 5.5 billion in 2026, and projected to reach USD 120.91 billion by 2034, reflecting a remarkable CAGR of 47.14% during the forecast period.

Artificial intelligence is being increasingly integrated across clinical trial design, execution, monitoring, and data analysis. These AI technologies help pharmaceutical companies and contract research organizations (CROs) reduce timelines, streamline patient recruitment, automate data cleaning, and enable adaptive trial designs. For example, in September 2022, IQVIA Inc. reported that decentralized clinical trials delivered measurable reductions in both time and cost compared to traditional trial workflows.

The market is dominated by companies such as IQVIA Inc., Dassault Systemes, and AiCure, with strong geographic presence, broad product portfolios, and innovative AI solutions supporting their leadership positions.

Market Dynamics

Market Drivers

Rising adoption of AI-based solutions to tackle high costs and complexity in clinical trials is a primary driver. AI allows faster patient recruitment, real-time monitoring, and predictive outcome modeling, resulting in reduced trial durations and lower failure risks. The increasing volume of clinical trials worldwide further accelerates AI adoption.

Market Restraints

Data privacy and regulatory compliance remain key restraints. Regulations like HIPAA in the U.S. and GDPR in Europe limit cross-border data exchange and multi-site collaborations, increasing operational costs and time. These factors slow adoption of AI in multinational clinical trials.

Market Opportunities

The expansion of clinical trials in emerging markets offers significant growth potential. Regions like Asia Pacific, Latin America, and Middle East & Africa provide cost advantages and untapped patient populations. AI can optimize fragmented healthcare data and trial logistics in these regions, enabling faster and efficient trial execution.

Market Challenges

Integration of AI solutions with traditional IT systems poses challenges. Legacy electronic data capture (EDC) systems, paper-based records, and fragmented IT infrastructure hinder seamless AI deployment. Even when AI tools are implemented, inefficiencies in integration can limit their potential.

Market Trends

A major trend is the shift toward decentralized and hybrid clinical trials, which include remote patient monitoring, telemedicine, and distributed investigational-product logistics. Adoption of decentralized clinical trial (DCT) models rose from 28% pre-pandemic to 87% post-pandemic, with 95% of sponsors planning increased use, showcasing the strong role of AI in supporting these models.

Segmentation Analysis

By Offering:

  • Services segment dominated in 2026 with 52.74% share, driven by outsourcing to CROs and specialized service providers.
  • Software/platforms complement services for data analytics, patient monitoring, and trial management.

By Technology:

  • Machine learning (ML) accounted for 55.90% share in 2026, widely applied for predictive analytics and trial optimization.
  • Natural language processing (NLP) is expected to grow at 44.74% CAGR during the forecast period.

By Application:

  • Patient recruitment & retention led in 2026 with 31.45% share, optimizing enrollment and reducing trial delays.
  • Predictive analytics & outcome modeling is projected to witness 52.05% growth.

By Specialty:

  • Oncology dominated in 2026 with 39.25% share, driven by complex drug molecules and use of AI for biomarkers.
  • Neurology is projected to grow at 48.98% CAGR during the forecast period.

By End-User:

  • Pharmaceutical companies dominated in 2025 with 59.9% share, leveraging large clinical datasets and partnerships for AI deployment.
  • CROs are projected to grow at 48.56% CAGR.

Regional Outlook

  • North America: Dominated with USD 1.98 billion in 2025, growing to USD 2.87 billion in 2026, driven by U.S. clinical trial investments. The U.S. market is expected to reach USD 2.64 billion in 2026.
  • Europe: Valued at USD 0.75 billion in 2025, with strong growth due to AI adoption in oncology and rare disease trials. UK, Germany, and France markets are projected to reach USD 0.23B, 0.26B, 0.14B respectively in 2026.
  • Asia Pacific: Estimated at USD 0.83 billion in 2025, with Japan, China, and India projected at USD 0.27B, 0.31B, 0.24B in 2026.
  • Latin America: USD 0.15 billion in 2025, moderate growth expected.
  • Middle East & Africa: GCC valued at USD 0.04 billion in 2025, growing steadily with modernization of trial infrastructure.

Competitive Landscape

The market is semi-consolidated, led by IQVIA, Dassault Systemes, AiCure, Insilico Medicine, TEMPUS, Median Technologies, Saama, IBM, NVIDIA, and Phesi. These players focus on AI-powered solutions for patient recruitment, protocol optimization, and clinical trial analytics.

Key Developments:

  • Sept 2025: PhaseV & Bioforum partnership for AI/ML-based clinical trials efficiency.
  • June 2025: Advarra introduced Council for Responsible AI in Clinical Trials.
  • April 2025: ConcertAI & Bayer AG multi-year agreement for AI-driven precision oncology trials.
  • March 2025: EMA cleared AIM-NASH AI tool for fatty liver disease severity identification.

Conclusion

The global AI in clinical trials market is projected to grow from USD 3.8 billion in 2025 to USD 120.91 billion by 2034, at a CAGR of 47.14%. Growth is driven by increasing clinical trial complexity, adoption of AI technologies in patient recruitment, predictive analytics, and decentralized trials. Despite challenges in data privacy, regulatory compliance, and legacy system integration, opportunities in emerging markets, oncology, and neurology clinical trials will continue to propel the market globally.

Segmentation By Offering

  • Software / Platforms
  • Services

By Technology

  • Machine Learning
  • Natural Language Processing
  • Others

By Application

  • Patient Recruitment & Retention
  • Trial Design & Protocol Optimization
  • Data Collection & Management
  • Predictive Analytics & Outcome Modeling
  • Others

By Specialty

  • Oncology
  • Neurology
  • Cardiovascular
  • Others

By End User

  • Pharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Others

By Geography

  • North America (By Offering, Technology, Application, Specialty, End User, and Country)
    • U.S.
    • Canada
  • Europe (By Offering, Technology, Application, Specialty, End User, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Offering, Technology, Application, Specialty, End User, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Offering, Technology, Application, Specialty, End User, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Offering, Technology, Application, Specialty, End User, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements Pertaining to the Artificial Intelligence in Clinical Trials
  • 4.2. Regulatory Scenario for Key Countries
  • 4.3. Challenges Faced During Adoption and Implementation of AI-based Solutions in Clinical Trials
  • 4.4. Key Performance Indicators for Artificial Intelligence in the Clinical Trials Market
  • 4.5. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.

5. Global AI in Clinical Trials Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Offering
    • 5.1.1. Software/Platforms
    • 5.1.2. Services
  • 5.2. Market Analysis, Insights and Forecast - By Technology
    • 5.2.1. Machine Learning
    • 5.2.2. Natural Language Processing
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Patient Recruitment & Retention
    • 5.3.2. Trial Design & Protocol Optimization
    • 5.3.3. Data Collection & Management
    • 5.3.4. Predictive Analytics & Outcome Modelling
    • 5.3.5. Others
  • 5.4. Market Analysis, Insights and Forecast - By Specialty
    • 5.4.1. Oncology
    • 5.4.2. Neurology
    • 5.4.3. Cardiovascular
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By End User
    • 5.5.1. Pharmaceutical Companies
    • 5.5.2. Contract Research Organizations (CROs)
    • 5.5.3. Others
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America AI in Clinical Trials Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Offering
    • 6.1.1. Software/Platforms
    • 6.1.2. Services
  • 6.2. Market Analysis, Insights and Forecast - By Technology
    • 6.2.1. Machine Learning
    • 6.2.2. Natural Language Processing
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Patient Recruitment & Retention
    • 6.3.2. Trial Design & Protocol Optimization
    • 6.3.3. Data Collection & Management
    • 6.3.4. Predictive Analytics & Outcome Modelling
    • 6.3.5. Others
  • 6.4. Market Analysis, Insights and Forecast - By Specialty
    • 6.4.1. Oncology
    • 6.4.2. Neurology
    • 6.4.3. Cardiovascular
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By End User
    • 6.5.1. Pharmaceutical Companies
    • 6.5.2. Contract Research Organizations (CROs)
    • 6.5.3. Others
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe AI in Clinical Trials Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Offering
    • 7.1.1. Software/Platforms
    • 7.1.2. Services
  • 7.2. Market Analysis, Insights and Forecast - By Technology
    • 7.2.1. Machine Learning
    • 7.2.2. Natural Language Processing
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Patient Recruitment & Retention
    • 7.3.2. Trial Design & Protocol Optimization
    • 7.3.3. Data Collection & Management
    • 7.3.4. Predictive Analytics & Outcome Modelling
    • 7.3.5. Others
  • 7.4. Market Analysis, Insights and Forecast - By Specialty
    • 7.4.1. Oncology
    • 7.4.2. Neurology
    • 7.4.3. Cardiovascular
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By End User
    • 7.5.1. Pharmaceutical Companies
    • 7.5.2. Contract Research Organizations (CROs)
    • 7.5.3. Others
  • 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.6.1. U.K.
    • 7.6.2. Germany
    • 7.6.3. France
    • 7.6.4. Spain
    • 7.6.5. Italy
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia Pacific AI in Clinical Trials Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Offering
    • 8.1.1. Software/Platforms
    • 8.1.2. Services
  • 8.2. Market Analysis, Insights and Forecast - By Technology
    • 8.2.1. Machine Learning
    • 8.2.2. Natural Language Processing
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Patient Recruitment & Retention
    • 8.3.2. Trial Design & Protocol Optimization
    • 8.3.3. Data Collection & Management
    • 8.3.4. Predictive Analytics & Outcome Modelling
    • 8.3.5. Others
  • 8.4. Market Analysis, Insights and Forecast - By Specialty
    • 8.4.1. Oncology
    • 8.4.2. Neurology
    • 8.4.3. Cardiovascular
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By End User
    • 8.5.1. Pharmaceutical Companies
    • 8.5.2. Contract Research Organizations (CROs)
    • 8.5.3. Others
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. Australia
    • 8.6.5. Southeast Asia
    • 8.6.6. Rest of Asia Pacific

9. Latin America AI in Clinical Trials Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Offering
    • 9.1.1. Software/Platforms
    • 9.1.2. Services
  • 9.2. Market Analysis, Insights and Forecast - By Technology
    • 9.2.1. Machine Learning
    • 9.2.2. Natural Language Processing
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Patient Recruitment & Retention
    • 9.3.2. Trial Design & Protocol Optimization
    • 9.3.3. Data Collection & Management
    • 9.3.4. Predictive Analytics & Outcome Modelling
    • 9.3.5. Others
  • 9.4. Market Analysis, Insights and Forecast - By Specialty
    • 9.4.1. Oncology
    • 9.4.2. Neurology
    • 9.4.3. Cardiovascular
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By End User
    • 9.5.1. Pharmaceutical Companies
    • 9.5.2. Contract Research Organizations (CROs)
    • 9.5.3. Others
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa AI in Clinical Trials Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Offering
    • 10.1.1. Software/Platforms
    • 10.1.2. Services
  • 10.2. Market Analysis, Insights and Forecast - By Technology
    • 10.2.1. Machine Learning
    • 10.2.2. Natural Language Processing
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Patient Recruitment & Retention
    • 10.3.2. Trial Design & Protocol Optimization
    • 10.3.3. Data Collection & Management
    • 10.3.4. Predictive Analytics & Outcome Modelling
    • 10.3.5. Others
  • 10.4. Market Analysis, Insights and Forecast - By Specialty
    • 10.4.1. Oncology
    • 10.4.2. Neurology
    • 10.4.3. Cardiovascular
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By End User
    • 10.5.1. Pharmaceutical Companies
    • 10.5.2. Contract Research Organizations (CROs)
    • 10.5.3. Others
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. GCC
    • 10.6.2. South Africa
    • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products & Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
    • 11.2.1. IQVIA Inc.
    • 11.2.2. Dassault Systemes
    • 11.2.3. AiCure
    • 11.2.4. Insilico Medicine
    • 11.2.5. TEMPUS
    • 11.2.6. Median Technologies
    • 11.2.7. Saama
    • 11.2.8. IBM
    • 11.2.9. NVIDIA Corporation
    • 11.2.10. Phesi

List of Tables

  • Table 1: Global AI in Clinical Trials Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 2: Global AI in Clinical Trials Market Revenue (USD billion) Forecast, By Technology, 2021-2034
  • Table 3: Global AI in Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 4: Global AI in Clinical Trials Market Revenue (USD billion) Forecast, By Specialty, 2021-2034
  • Table 5: Global AI in Clinical Trials Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 6: Global AI in Clinical Trials Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 7: North America AI in Clinical Trials Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 8: North America AI in Clinical Trials Market Revenue (USD billion) Forecast, By Technology, 2021-2034
  • Table 9: North America AI in Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 10: North America AI in Clinical Trials Market Revenue (USD billion) Forecast, By Specialty, 2021-2034
  • Table 11: North America AI in Clinical Trials Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 12: North America AI in Clinical Trials Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13: Europe AI in Clinical Trials Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 14: Europe AI in Clinical Trials Market Revenue (USD billion) Forecast, By Technology, 2021-2034
  • Table 15: Europe AI in Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 16: Europe AI in Clinical Trials Market Revenue (USD billion) Forecast, By Specialty, 2021-2034
  • Table 17: Europe AI in Clinical Trials Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 18: Europe AI in Clinical Trials Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 19: Asia Pacific AI in Clinical Trials Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 20: Asia Pacific AI in Clinical Trials Market Revenue (USD billion) Forecast, By Technology, 2021-2034
  • Table 21: Asia Pacific AI in Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 22: Asia Pacific AI in Clinical Trials Market Revenue (USD billion) Forecast, By Specialty, 2021-2034
  • Table 23: Asia Pacific AI in Clinical Trials Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 24: Asia Pacific AI in Clinical Trials Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Latin America AI in Clinical Trials Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 26: Latin America AI in Clinical Trials Market Revenue (USD billion) Forecast, By Technology, 2021-2034
  • Table 27: Latin America AI in Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 28: Latin America AI in Clinical Trials Market Revenue (USD billion) Forecast, By Specialty, 2021-2034
  • Table 29: Latin America AI in Clinical Trials Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 30: Latin America AI in Clinical Trials Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 31: Middle East & Africa AI in Clinical Trials Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 32: Middle East & Africa AI in Clinical Trials Market Revenue (USD billion) Forecast, By Technology, 2021-2034
  • Table 33: Middle East & Africa AI in Clinical Trials Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 34: Middle East & Africa AI in Clinical Trials Market Revenue (USD billion) Forecast, By Specialty, 2021-2034
  • Table 35: Middle East & Africa AI in Clinical Trials Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 36: Middle East & Africa AI in Clinical Trials Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global AI in Clinical Trials Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global AI in Clinical Trials Market Value Share (%), By Offering, 2025 & 2034
  • Figure 3: Global AI in Clinical Trials Market Value Share (%), By Technology, 2025 & 2034
  • Figure 4: Global AI in Clinical Trials Market Value Share (%), By Application, 2025 & 2034
  • Figure 5: Global AI in Clinical Trials Market Value Share (%), By Specialty, 2025 & 2034
  • Figure 6: Global AI in Clinical Trials Market Value Share (%), By End User, 2025 & 2034
  • Figure 7: Global AI in Clinical Trials Market Value (USD billion), by Region, 2025 & 2034
  • Figure 8: North America AI in Clinical Trials Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 9: North America AI in Clinical Trials Market Value Share (%), By Offering, 2025
  • Figure 10: North America AI in Clinical Trials Market Value (USD billion), By Technology, 2025 & 2034
  • Figure 11: North America AI in Clinical Trials Market Value Share (%), By Technology, 2025
  • Figure 12: North America AI in Clinical Trials Market Value (USD billion), By Application, 2025 & 2034
  • Figure 13: North America AI in Clinical Trials Market Value Share (%), By Application, 2025
  • Figure 14: North America AI in Clinical Trials Market Value (USD billion), By Specialty, 2025 & 2034
  • Figure 15: North America AI in Clinical Trials Market Value Share (%), By Specialty, 2025
  • Figure 16: North America AI in Clinical Trials Market Value (USD billion), By End User, 2025 & 2034
  • Figure 17: North America AI in Clinical Trials Market Value Share (%), By End User, 2025
  • Figure 18: North America AI in Clinical Trials Market Value (USD billion), By Country, 2025 & 2034
  • Figure 19: North America AI in Clinical Trials Market Value Share (%), By Country, 2025
  • Figure 20: Europe AI in Clinical Trials Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 21: Europe AI in Clinical Trials Market Value Share (%), By Offering, 2025
  • Figure 22: Europe AI in Clinical Trials Market Value (USD billion), By Technology, 2025 & 2034
  • Figure 23: Europe AI in Clinical Trials Market Value Share (%), By Technology, 2025
  • Figure 24: Europe AI in Clinical Trials Market Value (USD billion), By Application, 2025 & 2034
  • Figure 25: Europe AI in Clinical Trials Market Value Share (%), By Application, 2025
  • Figure 26: Europe AI in Clinical Trials Market Value (USD billion), By Specialty, 2025 & 2034
  • Figure 27: Europe AI in Clinical Trials Market Value Share (%), By Specialty, 2025
  • Figure 28: Europe AI in Clinical Trials Market Value (USD billion), By End User, 2025 & 2034
  • Figure 29: Europe AI in Clinical Trials Market Value Share (%), By End User, 2025
  • Figure 30: Europe AI in Clinical Trials Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 31: Europe AI in Clinical Trials Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 32: Asia Pacific AI in Clinical Trials Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 33: Asia Pacific AI in Clinical Trials Market Value Share (%), By Offering, 2025
  • Figure 34: Asia Pacific AI in Clinical Trials Market Value (USD billion), By Technology, 2025 & 2034
  • Figure 35: Asia Pacific AI in Clinical Trials Market Value Share (%), By Technology, 2025
  • Figure 36: Asia Pacific AI in Clinical Trials Market Value (USD billion), By Application, 2025 & 2034
  • Figure 37: Asia Pacific AI in Clinical Trials Market Value Share (%), By Application, 2025
  • Figure 38: Asia Pacific AI in Clinical Trials Market Value (USD billion), By Specialty, 2025 & 2034
  • Figure 39: Asia Pacific AI in Clinical Trials Market Value Share (%), By Specialty, 2025
  • Figure 40: Asia Pacific AI in Clinical Trials Market Value (USD billion), By End User, 2025 & 2034
  • Figure 41: Asia Pacific AI in Clinical Trials Market Value Share (%), By End User, 2025
  • Figure 42: Asia Pacific AI in Clinical Trials Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 43: Asia Pacific AI in Clinical Trials Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 44: Latin America AI in Clinical Trials Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 45: Latin America AI in Clinical Trials Market Value Share (%), By Offering, 2025
  • Figure 46: Latin America AI in Clinical Trials Market Value (USD billion), By Technology, 2025 & 2034
  • Figure 47: Latin America AI in Clinical Trials Market Value Share (%), By Technology, 2025
  • Figure 48: Latin America AI in Clinical Trials Market Value (USD billion), By Application, 2025 & 2034
  • Figure 49: Latin America AI in Clinical Trials Market Value Share (%), By Application, 2025
  • Figure 50: Latin America AI in Clinical Trials Market Value (USD billion), By Specialty, 2025 & 2034
  • Figure 51: Latin America AI in Clinical Trials Market Value Share (%), By Specialty, 2025
  • Figure 52: Latin America AI in Clinical Trials Market Value (USD billion), By End User, 2025 & 2034
  • Figure 53: Latin America AI in Clinical Trials Market Value Share (%), By End User, 2025
  • Figure 54: Latin America AI in Clinical Trials Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 55: Latin America AI in Clinical Trials Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 56: Middle East & Africa AI in Clinical Trials Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 57: Middle East & Africa AI in Clinical Trials Market Value Share (%), By Offering, 2025
  • Figure 58: Middle East & Africa AI in Clinical Trials Market Value (USD billion), By Technology, 2025 & 2034
  • Figure 59: Middle East & Africa AI in Clinical Trials Market Value Share (%), By Technology, 2025
  • Figure 60: Middle East & Africa AI in Clinical Trials Market Value (USD billion), By Application, 2025 & 2034
  • Figure 61: Middle East & Africa AI in Clinical Trials Market Value Share (%), By Application, 2025
  • Figure 62: Middle East & Africa AI in Clinical Trials Market Value (USD billion), By Specialty, 2025 & 2034
  • Figure 63: Middle East & Africa AI in Clinical Trials Market Value Share (%), By Specialty, 2025
  • Figure 64: Middle East & Africa AI in Clinical Trials Market Value (USD billion), By End User, 2025 & 2034
  • Figure 65: Middle East & Africa AI in Clinical Trials Market Value Share (%), By End User, 2025
  • Figure 66: Middle East & Africa AI in Clinical Trials Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 67: Middle East & Africa AI in Clinical Trials Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 68: Global AI in Clinical Trials Market Share (%), By Company, 2025